Alnylam Pharma (ALNY) Says DMC Recommends Continuation of Phase 3 APOLLO Trial
Tweet Send to a Friend
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) announced today that the Data Monitoring Committee (DMC) for the Phase 3 APOLLO study of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
